William Chase on Abbott's M&A strategy - The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)
Subscriber Content Preview | Request a free trialSearch  
  Go

Video

Share  |  Reprint

William Chase on Abbott's M&A strategy

Published November 19, 2012 at 1:04 PM


William Chase, Abbott Laboratories' vice president of licensing and acquisitions, and The Deal Pipeline's Ben Fidler discuss the pharmaceutical giant's acquisition strategy as it prepares to split into two different companies at the start of 2013. - George White

Share:

Meet the journalists



Movers & Shakers

Launch Movers and shakers slideshow

Oil and gas transactional lawyer Bryan Loocke joined Vinson & Elkins LLP as a partner from Bracewell & Giuliani LLP. For other updates launch today's Movers & shakers slideshow.

Video

M&A to flow to cardiac-focused medical devices

Following St. Jude Medical's acquisition of Thoratec, M&A in the medical device sector, especially devices related to the heart, is expected to take off. More video

Sectors